Posts for Ticker ‘KERX’

Top Day Trader Alerts (AEZS, KERX, AGCO, ACAS, CTIC, C, FLEX, CLS, SANM, JBL, OMTR, ADBE)

Money Stack ImageThese are this Wednesday morning’s top pre-market day trader alert and active trader alert stocks moving on unusual trading volume.  We have a link through to more color and analysis on price and volume over at VSInvestor.com on each stock:

AEterna Zentaris Inc. (NASDAQ: AEZS) and Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) are both ramping higher an FDA orphan-drug designation news.

Agco Corp. (AGCO) is trading lower by 7% on lower guidance.

American Capital Ltd. (NASDAQ: ACAS) is surging almost 20% after Corning Incorporated (NYSE: GLW) paid $400 million in cash for shares of another portfolio company.

Cell Therapeutics, Inc. (NASDAQ: CTIC) is up 5% on very active volume on more pixantrone for non-Hodgkin’s lymphoma news, but this is on positive data.

Citigroup, Inc. (NYSE: C) is up again on strong volume… we have color on prior day’s price levels here for inference.

Flextronics International Ltd. (NASDAQ: FLEX) is surging by almost 9% this morning after a Jim Cramer tout last night.. we are watching EMS rivals like Celestica Inc. (NYSE: CLS), Sanmina-SCI Corp. (NASDAQ: SANM) and Jabil Circuit Inc. (NYSE: JBL) on this.

Omniture, Inc. (NASDAQ: OMTR) is the biggest volume stock in the pre-market at NASDAQ after getting acquired by Adobe Systems, Inc. (NASDAQ: ADBE).

You can join our open email distribution list which goes out several times per week for top analyst upgrades and downgrades, top day trader alerts, IPO’s, key secondary offerings, guru investor data on Buffett and others, mergers, and more.

JON C. OGG
SEPTEMBER 16, 2009

Posted on: September 16, 2009 – 9:15 am in After-Hours Activity, Pre-Market Activity, Trading Alert, , , , , , , , , , , ,

The 52-Week Low Club (LVLT)(FNM)(C)(LEH)

Lehman (NYSE: LEH) hit by concerns about huge Q1 write-offs. Falls to $42.77 from 52-week high of $82.05.

Citigroup (NYSE: C) sells off because bank may have to raise more money. Down to $19.74 from 52-week high of $55.55.

Level 3 (NASDAQ: LVLT) loses its president, raises issues about next quarter. Sells down to $1.87 from 52-week high of $6.46.

Fannie Mae (NYSE: FNM) drops on negative comments in Barron’s. Sells off $18.50 from 52-week high of $70.57.

Thornburg Mortgage (NYSE: TMA) Capital calls raise concerns about bankruptcy. Goes down to $.75 from 52-week high of $28.40.

Keryx Biopharmaceuticals (NASDAQ: KERX) Big clinical trial falls short. Shares trade off to $.60 from 52-week high of $11.70.

Douglas A. McIntyre

Posted on: March 10, 2008 – 3:02 pm in HI/LOW, , , , , ,

Keryx Joins Biotech Zombie Ranks (KERX)

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) may have just joined the ranks of a biotech zombie, even if it doesn’t want to admit that.  The company announced that top-line results from its SUN-MICRO Phase III clinical trial of Sulonex for the treatment of diabetic nephropathy have failed to meet the primary objective of the study.  Unfortunately, this was Keryx’s lead product candidate.

The study was aimed to achieve therapeutic success at 6-months as compared to placebo. The results showed that Sulonex and the placebo appeared to be similar.  Interestingly enough, the company lost its CFO last summer.

It will focus efforts and resources on rapidly moving Zerenex forward for ESRD patients with hyperphosphatemia and Perifosine for cancer. It listed its goal of having Perifosine in a pivotal program this year and to be well into its Zerenex high-dose Phase II trial before the end of the year.

Keryx notes that while this is the end of one chapter, it is not the end of Keryx as it noted that it has built up a portfolio of potential product candidates.  Wall Street isn’t taking that at face value.  With the SUN-MICRO name, you’d think that disappointment there could have been expected. 

At the end of 2007 it had $62 million in cash and equivalents with another $2.296 million in long-term investments.  It also had $36.6 million in total liabilities.  Its market cap before today’s implosion was $230 million.  We don’t have to wonder for too long about how much capital it will have to burn through for these two other phase studies.

Keryx closed at $5.26 on Friday and its prior range over the last year had been $5.01 to $11.70.  Shares are trading down over 80% at $0.80 in pre-market activity.

Jon C. Ogg
March 10, 2008

Posted on: March 10, 2008 – 7:43 am in Biotech,

Top 10 Pre-Market Analyst Calls (ARO, ABH, FAST, JCP, JWN, KERX, MHS, AMTR, SHOR, SPLS, VE)

These are some of the analyst calls that 247WallSt.com is focusing on in early pre-market trading this Monday morning:

  • Aeropostale (NYSE: ARO) Cut To Sell From Hold at Citigroup.
  • AbitibiBowater (NYSE: ABH) Raised to Market Perform at Raymond James.
  • Fastenal (NASDAQ: FAST) Started as Equalweight at Morgan Stanley.
  • JC Penney (NYSE: JCP) & Nordstom (NYSE: JWN) Raised to Buy at Goldman Sachs.
  • Keryx Biopharmaceuticals (NASDAQ: KERX) Cut to Neutral at JP Morgan.
  • Medco Health Solutions (NYSE: MHS) Raised to Buy at Goldman Sachs.
  • Omniture (NASDAQ: AMTR) Raised To Outperform at FBR.
  • ShoreTel (NASDAQ: SHOR) Cut to Neutral at Piper Jaffray.
  • Staples (NASDAQ: SPLS) cut to Neutral at Goldman Sachs.
  • Veolia Environnement (NYSE: VE) Raised to Buy at Citigroup.

Jon C. Ogg
March 10, 2008

Posted on: March 10, 2008 – 6:31 am in Analyst Calls, , , , , , , , , , ,

52-Week Lows (July 13, 2007) (ACA, AVAV, IDIX, KERX, NKTR, REDE, STAA, TRMP, UBET, WON)

Stock Tickers: ACA, AVAV, IDIX, KERX, NKTR, REDE, STAA, TRMP, UBET, WON

The DJIA & S&P 500 Index may have put in new highs today, but as you know there are always a dingy group of little piggies putting in new 52-week lows.  Some companies are poorly run, and some are just victim of circumstance.  Maybe they can just all blame Friday the 13th.  Not all of these are definitely CLOSING on 52-week lows but some deserved the honorable mention.  Here are today’s little piggies:

(ACA) ACA CAPITAL HOLDINGS… Giving it up again, down 50% from Highs.  ACA provides financial guaranty insurance products to participants in the global credit derivative, structured finance capital, and municipal finance capital markets.  You think subprime or CDO blow-ups snuck into their pocketbook?

(AVAV) AEROVIRONMENT INC… Shares traded down another 2.4% and traded down into the ‘teens’ for the first time since its IPO in January.  No one realized that its flying re-con plane was needed to find stock buyers rather than enemy soldiers over the horizon.

(IDIX) IDENIX PHARMACEUTICALS… Whoops, FDA halts Hep-C trials. Ouch!

(KERX)    KERYX BIOPHARMA… no real news, just days and days of weakness.

(NKTR) NEKTAR THERAPEUTICS… no real news, just days of weakness.

(REDE) RED ENVELOPE… no real news, although for an ‘online of high-end gifts’ it is pretty shocking that I have yet to meet anyone who has bought from them online.

(STAA) STAAR SURGICAL… very thin volume, no news; not being run by stars?

(TRMP) TRUMP ENTERTAINMENT… The truth is that this DIDN’T CLOSE on a low, but it hit a new since coming public after the recapitalization in 2005 and deserves to be noted.  Hopefully The Donald won’t sue us for saying something negative like he has been known to do, but this stock has been a stinker.

(UBET) YOUBET.COM… You can bet it is hard to find bulls or bears in this name.

(WON) WESTWOOD ONE INC… This was down close to 15% at one point but managed to come all the way back on 4-times average volume to a 10-year ("TEN") after traders bought it back up after Citigroup downgraded it.

Jon C. Ogg
July 13, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: July 13, 2007 – 3:03 pm in HI/LOW, , , , , , , , , ,

Pre-Market Stock News (June 18, 2007)

(AA) An ALCOA bid from BHP may be kindled according to numerous M&A reports.
(ADVNA) Advanta trades ex-split to reflect a 3-2 stock split.
(AGU) Agrium said earnings will be at or above the upper end of its $1.45 to $1.55 range.
(BBI) Blockbuster is going to favor the Blu-Ray HD discs.
(BNHNA) Benihana $0.35 EPS vs $0.30e.
(BWLD) Buffalo Wild Wings trades ex-split to reflect a 2-1 stock split.
(CEPH) Cephalon received FDA Marketing approval of Nuvigil for excessive sleepiness.
(CVTX) CV Therapeutics traded up on Cramer recommendation.
(DJ) Dow Jones may get a rival bid from Pearson and General Electric.
(ECIL) ECI Telecom in discussions for potential takeovers at $10.00 per share.
(ENCY) Encysive Pharma trading down 50%; announced third ‘approvable’letter from FDA for Thelin for treating pulmonary arterial hypertension, but it did not demonstrate the evidence of effectiveness needed for approval and may have to drastically cut costs.
(ESC) Emeritus Corp announces a 10.5 million share common stock offering; 9 million shares were from the company and 1.5 million from selling shareholders.
(FRN) Friendly Ice Cream going private at $15.50.
(FTEK) Fuel-Tech gets two orders totaling $2 million.
(GCO) Genesco gets $54.50 per share offer and buyout from Finish Line.
(KERX) Keryx Bio announced its CFO is resigning.
(LXRX) Lexicon Pharma secured a major investment in the company as a two part investment: $205 million and $60 million.
(MSFT) Microsoft making investment in Chinese television and media makers to change IPTV to Mediaroom.
(NVDA) NVIDIA noted as speculative chip play by Cramer.
(OBAS) Optibase won encoder pact from Huawei for IPTV.
(PAY) Verifone announced a $275 million senior convertible note offering.
(THRM) Thermage says FDA clears indication for Thermacool system.
(VICL) Vical licensee AnGes MG announces positive results of Phase 3 angiogenesis trial in Japan.
(VRAZ) Veraz platform chosen by Golden Telecom for an upgrade of its TDM network to a next-generation network.
(XFML) Xinhua Finance Media wins contract to re-brand Hebei Movie & Drama TV channel.

Jon C. Ogg
June 18, 2007

Posted on: June 18, 2007 – 6:53 am in Pre-Market Activity, , , , , , , , , , , , , , , , , , , , , , , , ,